RMCM
CVS icon

Reynders McVeigh Capital Management’s CVS Health CVS Stock Holding History

Reynders McVeigh Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,869
Closed -$228K – 200
2025
Q4 		$228K Buy
+2,869
New +$226K 0.01% 184
2024
Q4 		– Sell
-6,053
Closed -$381K – 203
2024
Q3 		$381K Sell
6,053
-16,408
-73% -$957K 0.02% 154
2024
Q2 		$1.33M Sell
22,461
-197,945
-90% -$12.4M 0.08% 86
2024
Q1 		$17.6M Sell
220,406
-38,030
-15% -$2.9M 1.01% 34
2023
Q4 		$20.4M Sell
258,436
-16,199
-6% -$1.15M 1.29% 29
2023
Q3 		$19.2M Sell
274,635
-1,307
-0.5% -$92.6K 1.32% 28
2023
Q2 		$19.1M Sell
275,942
-16,907
-6% -$1.2M 1.25% 28
2023
Q1 		$21.8M Buy
292,849
+3,072
+1% +$258K 1.5% 23
2022
Q4 		$27M Buy
289,777
+6,072
+2% +$586K 1.98% 19
2022
Q3 		$27.1M Buy
283,705
+8,134
+3% +$805K 2.1% 19
2022
Q2 		$25.5M Buy
275,571
+11,183
+4% +$1.09M 1.92% 19
2022
Q1 		$26.8M Buy
264,388
+14,071
+6% +$1.48M 1.64% 25
2021
Q4 		$25.8M Buy
250,317
+5,789
+2% +$535K 1.46% 25
2021
Q3 		$20.8M Buy
244,528
+11,283
+5% +$945K 1.27% 30
2021
Q2 		$19.5M Sell
233,245
-3,845
-2% -$315K 1.19% 30
2021
Q1 		$17.8M Sell
237,090
-21,984
-8% -$1.6M 1.19% 29
2020
Q4 		$17.7M Buy
259,074
+1,979
+0.8% +$129K 1.21% 31
2020
Q3 		$15M Buy
257,095
+23,677
+10% +$1.47M 1.16% 33
2020
Q2 		$15.2M Buy
233,418
+29,811
+15% +$1.88M 1.33% 29
2020
Q1 		$12.1M Buy
203,607
+58,408
+40% +$3.9M 1.38% 30
2019
Q4 		$10.8M Sell
145,199
-614
-0.4% -$43.1K 1.04% 32
2019
Q3 		$9.2M Sell
145,813
-2,324
-2% -$138K 0.98% 32
2019
Q2 		$8.07M Sell
148,137
-3,647
-2% -$196K 0.87% 32
2019
Q1 		$8.19M Sell
151,784
-5,492
-3% -$339K 0.91% 32
2018
Q4 		$10.3M Sell
157,276
-3,982
-2% -$297K 1.37% 24
2018
Q3 		$12.7M Sell
161,258
-19,137
-11% -$1.37M 1.49% 23
2018
Q2 		$11.6M Sell
180,395
-49,823
-22% -$3.28M 1.48% 23
2018
Q1 		$14.3M Sell
230,218
-34,465
-13% -$2.47M 1.81% 21
2017
Q4 		$19.2M Sell
264,683
-79,360
-23% -$5.77M 2.52% 14
2017
Q3 		$28M Buy
344,043
+2,157
+0.6% +$171K 3.65% 6
2017
Q2 		$27.5M Buy
341,886
+2,946
+0.9% +$233K 3.68% 4
2017
Q1 		$26.6M Sell
338,940
-6,147
-2% -$491K 3.65% 4
2016
Q4 		$27.2M Buy
345,087
+3,877
+1% +$314K 3.87% 2
2016
Q3 		$30.4M Sell
341,210
-5,694
-2% -$537K 4.42% 2
2016
Q2 		$33.2M Sell
346,904
-2,947
-0.8% -$294K 4.82% 1
2016
Q1 		$36.3M Buy
349,851
+15,948
+5% +$1.55M 5.37% 1
2015
Q4 		$32.6M Buy
333,903
+13,640
+4% +$1.34M 5.35% 1
2015
Q3 		$30.9M Buy
320,263
+4,218
+1% +$443K 5.38% 1
2015
Q2 		$33.1M Sell
316,045
-4,776
-1% -$488K 5.41% 1
2015
Q1 		$33.1M Sell
320,821
-2,275
-0.7% -$230K 5.69% 1
2014
Q4 		$31.1M Sell
323,096
-1,850
-0.6% -$163K 5.46% 1
2014
Q3 		$25.9M Buy
324,946
+52,410
+19% +$4.13M 4.92% 1
2014
Q2 		$20.5M Sell
272,536
-2,230
-0.8% -$169K 4.68% 1
2014
Q1 		$20.6M Buy
274,766
+590
+0.2% +$41.7K 4.87% 2
2013
Q4 		$19.6M Buy
274,176
+3,630
+1% +$233K 4.86% 2
2013
Q3 		$15.4M Buy
270,546
+3,855
+1% +$230K 4.26% 2
2013
Q2 		$15.2M Buy
+266,691
New +$15.5M 4.52% 2

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Reynders McVeigh Capital Management's CVS Position: Q1 2026 in Review

Reynders McVeigh Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,869 shares — an estimated $228K sold.

Reynders McVeigh Capital Management first reported a position in CVS in Q2 2013 and held it in 47 quarters. The position peaked at $36.3M in Q1 2016. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Reynders McVeigh Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 2,869 CVS Health shares in Q1 2026, an estimated $228K.
  • Reynders McVeigh Capital Management first reported a position in CVS Health in Q2 2013 and held it in 47 quarters.
  • Reynders McVeigh Capital Management's CVS Health position peaked at $36.3M in Q1 2016.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.